Global Cord Blood Corp
CO
Get informed when a big investor buys or sells
+ FollowMarket Cap$400.08M
Close$
$52.96
1672.6% upside
Current Fair Value
1672.6% upsideUndervalued by 1672.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $400.08 Million |
|---|---|
| Enterprise Value | $-578,347,546.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $4.12 |
| Beta | -0.04 |
| Outstanding Shares | 121,763,000 |
Return
| Return on Equity | 61.43% |
|---|---|
| Return on Assets | 35.12% |
| Return on Invested Capital | 47.77% |
Valuation & Multiples
| P/E Ratio | 1.54 |
|---|---|
| PEG | -7.11 |
| Price to Sales | 0.3 |
| Price to Book Ratio | 0.5 |
| Enterprise Value to Revenue | -0.47 |
| Enterprise Value to EBIT | -0.97 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | -0.13 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Global Cord Blood Corp
1,202 employees
CEO: Ting Zheng Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive...